Comparing Entyvio vs Remicade
| Entyvio Remove Entyvio from your drug comparison | Remicade Remove Remicade from your drug comparison |
|
|---|
| Entyvio vedolizumab Remove Entyvio from your drug comparison | Remicade infliximab Remove Remicade from your drug comparison |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Entyvio is an integrin receptor antagonist that may be used to reduce inflammation associated with moderate to severe ulcerative colitis or Crohn's disease. It targets the gut specifically instead of... View more |
Prescribed for Ankylosing Spondylitis, Crohn's Disease - Maintenance, Crohn's Disease, Crohn's Disease - Acute, Inflammatory Bowel Disease, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis... View more |
||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
Common side effects include: nasopharyngitis. See the full Entyvio side effects document. |
Common side effects include: abdominal pain, back pain, chest pain, and nausea. See the full Remicade side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Entyvio prices |
View all Remicade prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
No |
No |
||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
|
N/A |
Other infliximab brands include: Avsola, Inflectra, Ixifi, Renflexis | ||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
600 hours |
228 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
A total of 113 drugs are known to interact with Entyvio:
|
A total of 419 drugs are known to interact with Remicade:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
|
May 20, 2014 |
August 24, 1998 |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.